Fundamental Analysis
59 / 100BRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +4.7% | +110.3% | 2 / 3 | +11.1% | +1.45 pp | -0.03 pp | +18.4% | 0.00 | 7.14 | 561 | +11,1% | 3,1 | +4,7% | 7.14 | 6.57 | +8,7% |
| Pts | 0 | 12 | 8 | 4 | 8 | 4 | 8 | 12 | 8 | |||||||
Valuation annotation:Price: 30.000 (close price on 2026-10-15)EPS (TTM): 4.200
Financial charts
1.Revenue & growth
VND bn561Q2/26
1.Revenue & growth
VND bn561Q2/26
2.Profit & growth
VND bn3,05Q2/26
3.Profit mix (Penman)
VND bn16,4Q2/26
4.Margins & cost structure
%6.4%Q2/26
5.Returns & cash cycle
% · days18.2%Q2/26
6.Earnings quality & cash
VND bn-20,3Q2/26
7.Asset structure
VND bn216Q2/26
8.Funding & debt health
VND bn · times216Q2/26
9.Revenue backlog
VND bn12,1Q2/26
10.Valuation
times · %7,1×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %978Q2/26
Adjusted EPS growth, latest quarter
4.7%
Average adjusted EPS growth, 3 quarters
110%
Quarters at 25%+ growth
1/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26